Evidence map›Paper›PMID 37235056›Full record

ArticleiScience2023

Dominant-negative heterozygous mutations in AIRE confer diverse autoimmune phenotypes.

Bergithe E Oftedal, Kristian Assing, Safa Baris, Stephanie L Safgren, Isik S Johansen, Marianne Antonius Jakobsen, Dusica Babovic-Vuksanovic, Katherine Agre, Eric W Klee, Emina Majcic and 15 more

Open access · goldAbstract read
In one paragraph

Article in iScience, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 30 citations in OpenAlex.

  1. Approach to the patient with APS-1/APECED.The Journal of clinical endocrinology and metabolism · 2026
    Article
  2. Article
  3. Observational
  4. Article
  5. Long-term follow-up of autoimmune polyendocrine syndrome type 1 in Norway.The Journal of clinical endocrinology and metabolism · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Systematic and proactive evaluation of AIRE missense variant effects.bioRxiv : the preprint server for biology · 2025
    Article
  14. Review
  15. A novel heterozygous pathogenicJournal of human immunity · 2025
    Article
  16. Article
  17. Thymic inborn errors of immunity.The Journal of allergy and clinical immunology · 2025
    Review
  18. Article
  19. Aire Mutations and Autoimmune Diseases.Advances in experimental medicine and biology · 2025
    Review
  20. Intracranial infections ofFrontiers in immunology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 15 institutions in 7 countries.

Bergithe E OftedalDepartment of Clinical Science, University of Bergen and Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Kristian AssingDepartment of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Safa BarisMarmara University, Faculty of Medicine, Pediatric Allergy and Immunology, Istanbul, Turkey.
Stephanie L SafgrenCenter for Individualized Medicine, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA.
Isik S JohansenDepartment of Infectious Diseases, Odense University Hospital, Odense, Denmark.
Marianne Antonius JakobsenDepartment of Clinical Immunology, Odense University Hospital, Odense, Denmark.
Dusica Babovic-VuksanovicDepartment of Clinical Genomics, Mayo Clinic, Rochester, MN, USA.
Katherine AgreInvitae, San Francisco, CA, USA.
Eric W KleeMayo Clinic, Department of Quantitative Health Sciences, Rochester, MN, USA.
Emina MajcicDepartment of Clinical Science, University of Bergen and Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Elise M N FerréLaboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Monica M SchmittLaboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Tom DiMaggioLaboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Lindsey B RosenLaboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Muhammad Obaidur RahmanDepartment of Clinical Science, University of Bergen and Department of Medicine, Haukeland University Hospital, Bergen, Norway.
Dionisios ChrysisDepartment of Pediatrics, Division of Pediatric Endocrinology, Medical School, University of Patras, Rion, Greece.
Aristeidis GiannakopoulosDepartment of Pediatrics, Division of Pediatric Endocrinology, Medical School, University of Patras, Rion, Greece.
Maria Tallon GarciaPediatric Hematology and Oncology Department, Hospital Álvaro Cunqueiro, Vigo, Spain.
Luis Ignacio González-GranadoUnidad de Inmunodeficiencias, Pediatría, Instituto de Investigación Hospital 12 de Octubre, Facultad de Medicina, Universidad Complutense, Madrid, Spain.
Katherine StanleyMid-Atlantic Permanente Medical Group, Kaiser Permanente MidAtlantic, Rockville, MD, USA.
Jessica Galant-SwaffordDivision of Allergy & Clinical Immunology, National Jewish Health, Denver, CO, USA.
Pim SuwannaratMid-Atlantic Permanente Medical Group, Kaiser Permanente MidAtlantic, Rockville, MD, USA.
Isabelle MeytsDepartment of Pediatrics, University Hospital Leuven, Laboratory for Inborn Errors of Immunity, Department of Microbiology Immunology and Transplantation, KU Leuven, Leuven, Belgium.
Michail S LionakisLaboratory of Clinical Immunology & Microbiology, National Institute of Allergy & Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, MD, USA.
Eystein S HusebyeDepartment of Clinical Science, University of Bergen and Department of Medicine, Haukeland University Hospital, Bergen, Norway.
National Institute of Allergy and Infectious Diseases · USOdense University Hospital · DKUniversity of Bergen · NOKaiser Permanente · USMayo Clinic in Florida · USNational Institutes of Health · USUniversity of Patras · GRHaukeland University Hospital · NOInvitae (United States) · USKU Leuven · BEMarmara University · TRMayo Clinic · USNational Jewish Health · USResearch Institute Hospital 12 de Octubre · ESUniversity Hospital Complex Of Vigo · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive disease characterized by severe and childhood onset organ-specific autoimmunity caused by mutations in the autoimmune regulator (

Indexed as

Human GeneticsMolecular genetics

Identifiers

PMID37235056
PMCPMC10206195
OpenAlexW4372218892

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.